4.6 Article

Graphene based magnetic nanocomposites as versatile carriers for high yield immobilization and stabilization of β-galactosidase

Journal

RSC ADVANCES
Volume 6, Issue 58, Pages 53493-53503

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c6ra06960f

Keywords

-

Funding

  1. 'SRF' by 'UGC-MANF, New Delhi'

Ask authors/readers for more resources

The present study demonstrates an efficient method for high yield immobilization of Aspergillus oryzae beta-galactosidase onto graphene-iron oxide nanocomposites (Gr@Fe3O4 NCs) by a simple adsorption mechanism. The synthesized nanocomposites were characterized by X-ray diffraction and FT-Raman spectroscopy, and by vibrating sample magnetometry. The binding of the enzyme onto the nanocomposites was confirmed by transmission electron microscopy, scanning electron microscopy, and Fourier transform-infrared spectroscopy. The bound enzyme showed 90% immobilization yield. The adsorbed and free enzyme both exhibited the same pH-optima at pH 4.5. However, the immobilized enzyme showed enhanced pH stability toward acidic and basic extremes, as well as increased temperature resistance as compared to native beta-galactosidase. The Michaelis constant, K-m decreased, while V-max increased, which indicates a higher affinity and activity retention by immobilized beta-galactosidase. The bound enzyme retained 83% activity even after its 8th successive reuse. The adsorbed enzyme lost only 21% of its initial activity during storage at 4 degrees C, while the free b-galactosidase retained only 49% activity under similar storage conditions. The genotoxicity assessment revealed that the nanocomposites showed negligible toxicity to pBR(322) DNA plasmid and human lymphocytes. In view of its easy production, non-toxic nature, improved stability against various denaturants and excellent reusability, the versatile Gr@Fe3O4 NCs can serve as an ideal support for the immobilization of other enzymes as well, and it may find applications in constructing biosensors and producing lactose-free dairy products to feed lactose intolerant patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available